US Stock MarketDetailed Quotes

LUMO Lumos Pharma (Delisted)

Watchlist
  • 4.340
  • 0.0000.00%
Close Dec 11 16:00 ET
37.54MMarket Cap-1.01P/E (TTM)

About Lumos Pharma (Delisted) Company

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.

Company Profile

SymbolLUMO
Company NameLumos Pharma (Delisted)
Issue Price7.00
CEOMr. Richard J. Hawkins
MarketNASDAQ
Employees33
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Richard J. Hawkins
  • Chairman of the Board and Chief Executive Officer
  • 952.87K
  • Lori Lawley
  • Chief Financial Officer, Secretary and Principal Accounting Officer
  • 569.78K
  • Dr. John C. McKew, PhD
  • President and Chief Scientific Officer
  • 904.79K
  • Chad A. Johnson, J.D.
  • Independent Director
  • 64.33K
  • Dr. An van Es-Johansson, M.D.
  • Independent Director
  • 52.83K
  • Lota S. Zoth, C.P.A.
  • Independent Director
  • 69.33K
  • Kevin M. Lalande
  • Independent Director
  • 54.33K
  • Dr. Joseph S. McCracken, D.V.M.
  • Independent Director
  • 56.33K
  • Dr. Thomas A. Raffin, M.D.
  • Lead Independent Director
  • 86.83K
  • Bradley J. Powers
  • General Counsel
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data